Last update Nov. 18, 2024

Xeljanz™

Tofacitinib (active ingredient of Xeljanz):

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding. Read the Commentary., is now set to Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Level of risk reviewed on Nov. 17, 2024

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Xeljanz is a tradename that contains a main active ingredient in its composition:

  • Tofacitinib (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)

For more information (pharmacokinetics, references, ...) tap the name of the active ingredient.

Note: The composition of certain tradenames varies in each country. Please, make sure this is the composition of the tradename you are looking for..

Alternatives

  • Adalimumab (Safe product and/or breastfeeding is the best option.)
  • Certolizumab (Safe product and/or breastfeeding is the best option.)
  • Etanercept (Safe product and/or breastfeeding is the best option.)
  • Hydroxychloroquine Sulfate (Safe product and/or breastfeeding is the best option.)
  • Infliximab (Safe product and/or breastfeeding is the best option.)
  • Penicillamine (Safe product and/or breastfeeding is the best option.)
  • Sulfasalazine (Safe product and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Total visits

1,554

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM